Ginkgo Bioworks (DNA) Projected to Post Quarterly Earnings on Tuesday

Ginkgo Bioworks (NYSE:DNA) will likely be posting its Q1 2025 quarterly earnings results after the market closes on Tuesday, May 6th. Analysts expect Ginkgo Bioworks to post earnings of ($1.23) per share and revenue of $38.70 million for the quarter.

Ginkgo Bioworks Stock Performance

NYSE:DNA opened at $7.04 on Monday. The company has a fifty day moving average of $7.24 and a two-hundred day moving average of $9.14. Ginkgo Bioworks has a fifty-two week low of $5.00 and a fifty-two week high of $41.20. The stock has a market capitalization of $408.56 million, a PE ratio of -0.54 and a beta of 1.34.

About Ginkgo Bioworks

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.